Stocks › JNJ
JOHNSON & JOHNSON
JNJ·NYSE·
United States·USD
$270.47
+3.33 (+1.25%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
JNJ
JOHNSON & JOHNSON · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
JNJS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of JNJ by members of U.S. Congress · 527 on record · 42 in the last 12 months
Whale Activity
Position changes in JNJ reported for 2026-09-30 by 4838 institutional filers
- Increased1968
- New166
- Held499
- Decreased1911
- Closed94
- No prior filing200
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 209.7M | $55.52B | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 157.8M | $41.76B | increased |
| STATE STREET CORP | 134.0M | $35.47B | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 65.7M | $17.38B | increased |
| GEODE CAPITAL MANAGEMENT, LLC | 65.5M | $17.30B | increased |
| JPMORGAN CHASE & CO | 61.8M | $16.52B | increased |
| MORGAN STANLEY | 44.7M | $11.83B | decreased |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 31.6M | $8.36B | held |
| NORTHERN TRUST CORP | 28.2M | $7.46B | decreased |
| Capital World Investors | 26.3M | $6.97B | increased |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 23.1M | $6.12B | increased |
| BANK OF AMERICA CORP /DE/ | 22.8M | $6.03B | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by JNJ insiders, by quarter · Form 4
Recent Insider Transactions
2,039 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Forminard ElizabethEVP, Chief Legal Officer | Sale | −13.1K | $284.39 | $3.7M | Nov 12, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Sale | −22.5K | $274.74 | $6.2M | Sep 2, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Option exercise | +22.5K | $151.41 | $3.4M | Sep 2, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Sale | −11.1K | $274.74 | $3.0M | Sep 2, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Option exercise | +11.1K | $131.94 | $1.5M | Sep 2, 2026 | Form 4 ↗ |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Sale | −15.0K | $263.36 | $4.0M | Aug 17, 2026 | Form 4 ↗ |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Option exercise | +15.0K | $115.67 | $1.7M | Aug 17, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −102.3K | $261.00 | $26.7M | Aug 13, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −21.0K | $262.00 | $5.5M | Aug 13, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Option exercise | +123.3K | $115.67 | $14.3M | Aug 13, 2026 | Form 4 ↗ |
| Forminard ElizabethEVP, Chief Legal Officer | Sale | −6,574 | $255.93 | $1.7M | Aug 6, 2026 | Form 4 ↗ |
| Forminard ElizabethEVP, Chief Legal Officer | Sale | −9,344 | $257.76 | $2.4M | Aug 6, 2026 | Form 4 ↗ |
| Forminard ElizabethEVP, Chief Legal Officer | Option exercise | +9,344 | $131.94 | $1.2M | Aug 6, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −6,523 | $258.74 | $1.7M | Aug 5, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −42.0K | $258.06 | $10.8M | Aug 5, 2026 | Form 4 ↗ |
| Broadhurst VanessaEVP, Global Corp Affairs | Sale | −23.1K | $251.27 | $5.8M | Jul 20, 2026 | Form 4 ↗ |
| Broadhurst VanessaEVP, Global Corp Affairs | Option exercise | +11.9K | $131.94 | $1.6M | Jul 20, 2026 | Form 4 ↗ |
| Broadhurst VanessaEVP, Global Corp Affairs | Option exercise | +11.1K | $129.51 | $1.4M | Jul 20, 2026 | Form 4 ↗ |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Sale | −10.0K | $241.15 | $2.4M | Jun 11, 2026 | Form 4 ↗ |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Option exercise | +10.0K | $115.67 | $1.2M | Jun 11, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding JNJ · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 76.4M | $19.41B | 0.84% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 62.4M | $15.84B | 0.95% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 33.1M | $8.41B | 0.95% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 31.2M | $8.31B | 0.97% | Aug 31, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 29.2M | $7.41B | 0.95% | Jun 30, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 22.9M | $5.82B | 2.29% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 17.0M | $4.32B | 10.64% | Jun 30, 2026 |
| VANGUARD DIVIDEND APPRECIATION INDEX FUND VANGUARD SPECIALIZED FUNDS | 13.6M | $3.49B | 2.67% | Jul 31, 2026 |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 13.1M | $3.32B | 0.95% | Jun 30, 2026 |
| VANGUARD HIGH DIVIDEND YIELD INDEX FUND VANGUARD WHITEHALL FUNDS | 9.7M | $2.49B | 2.51% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list JNJ's shares (CUSIP 478160104), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming johnson johnson as client
- HART HEALTH STRATEGIESJOHNSON & JOHNSON SERVICES INC · 2026 Q3—
Filing ↗ - HART HEALTH STRATEGIESJOHNSON & JOHNSON SERVICES INC · 2026 Q3—
Filing ↗ - NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC)JOHNSON & JOHNSON SERVICES, INC · 2026 Q3 · HCR, BUD, TOR$60K
Filing ↗ - SPLITOAK STRATEGIES LLCJOHNSON & JOHNSON SERVICES, INC. · 2026 Q3 · MMM$50K
Filing ↗ - JOHNSON & JOHNSON SERVICES, INC.JOHNSON & JOHNSON SERVICES INC · 2026 Q3 · HCR, BUD, CPT, LAW$2.2M
Filing ↗
Government Contracts
Federal awards to johnson johnson · USAspending
$4.7MAwarded · 181 contracts on record
- Department of Defense4572561872!LOCKING SCREW FOR MEDULLARY NAIL, 5 MM,$3K
Jul 31, 2026 · ↗ - Department of Defense4572754735!PELVIC REDUCTION FORCEPS WITH$84K
Aug 19, 2026 · ↗ - Department of DefenseIGF::OT::IGF:: CUSTOMVUE LICENSE FEE$123K
Jan 10, 2018 · ↗ - Department of DefenseIGF::OT::IGF:: CUSTOMVUE LICENSE FEE$123K
Jan 9, 2018 · ↗ - Department of Health and Human ServicesJOHNSON & JOHNSON HEALTH CARE SYSTEMS INC:1106694 [22-012035]$13K
Jul 14, 2022 · ↗ - Department of Defense4572689655!2.5MM KIRSCHNER WIRE W/15MM$3K
Aug 12, 2026 · ↗ - Department of Defense4572694926!2.0MM CANN DRILL BIT$4K
Aug 14, 2026 · ↗ - Department of Defense4572637514!SUT MNCRL MTPS 4-0 PS2 27IN MFL UD ABS$732
Aug 10, 2026 · ↗
U.S. Patents
Recent USPTO applications naming JOHNSON & JOHNSON
No USPTO patent applications found for JOHNSON & JOHNSON.
Annual Financials
From JNJ's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $94.19B | $88.82B | $85.16B | $79.99B | $78.74B |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B |
| Diluted EPS | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 |
| Operating cash flow | $24.53B | $24.27B | $22.79B | $21.19B | $23.41B |
| Cash and equivalents | $19.71B | $24.11B | $21.86B | $12.89B | $14.49B |
| Total assets | $199.21B | $180.10B | $167.56B | $187.38B | $182.02B |
| Total liabilities | $117.67B | $108.61B | $98.78B | $110.57B | $108.00B |
As JOHNSON & JOHNSON tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 11, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitJun 13, 2001
- 2-for-1Stock splitJun 12, 1996
- 2-for-1Stock splitJun 10, 1992
- 2-for-1Stock splitMay 11, 1989
- 3-for-1Stock splitMay 19, 1981
- 3-for-1Stock splitMay 18, 1970
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsOct 13, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeAug 4, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJul 29, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJul 28, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 15, 2026
EDGAR ↗ - 8-K · Items 5.07, 9.01Shareholder voteApr 28, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsApr 14, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJan 21, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsOct 14, 2025
EDGAR ↗ - 8-K · Items 5.02Officer / director changeSep 9, 2025
EDGAR ↗
About JOHNSON & JOHNSON
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersNEW BRUNSWICK, NJ
IncorporatedNJ
SEC CIK0000200406 ↗
Former namesJOHNSON & JOHNSON ET AL







